SB 2384 ND
A BILL for an Act to provide for a legislative management study relating to vaccines for respiratory syncytial virus and vaccines developed using messenger ribonucleic acid technology.
A state bill is a proposed law in a state legislature — separate from the U.S. Congress. Learn more →
Summary
Relating to vaccines for respiratory syncytial virus and vaccines developed using messenger ribonucleic acid technology.
Sponsor (1)
- Jeffery J. Magrum Republican · primary
3 coauthors / cosponsors
- David A. Clemens Republican · cosponsor
- Scott Dyk · cosponsor
- Jeff A. Hoverson Republican · cosponsor
Action history (13)
- Jan 23, 2023 Introduced, first reading, referred Human Services Committee · upper
- Feb 7, 2023 Committee Hearing 09:30 · upper
- Feb 8, 2023 Committee Hearing 03:44 · upper
- Feb 9, 2023 Reported back, do not pass, placed on calendar 6 0 0 · upper
- Feb 9, 2023 Amendment proposed on floor · upper
- Feb 9, 2023 Amendment adopted · upper
- Feb 9, 2023 Second reading, passed, yeas 25 nays 22 · upper
- Feb 10, 2023 Received from Senate · lower
- Feb 17, 2023 Introduced, first reading, referred Human Services Committee · lower
- Mar 15, 2023 Committee Hearing 02:30 · lower
- Apr 3, 2023 Committee Hearing 03:30 · lower
- Apr 3, 2023 Reported back, do not pass, placed on calendar 7 6 1 · lower
- Apr 4, 2023 Second reading, failed to pass, yeas 38 nays 53 · lower
Full text
The full text hasn’t been imported yet. CivicGate fetches it from the state legislature’s published version documents — check now.
Comments
Data from OpenStates. View on OpenStates →
Comments